Serum BMP4 levels in patients with NAFLD were notably higher than those in the healthy participants (806.45 ± 327.16 vs. 601.26 ± 187.25 pg/mL, P = 0.002) as presented in Fig. 1a. Here, BMP4 is linked to metabolic dysfunction-associated steatotic liver disease.